Ryan M. Carr

Oncology

120 Frank Martin Rd
Ste 102
Shelbyville, TN 37160

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Epigenomic profiling links IGF2 overexpression to anthracycline resistance in colorectal cancer organoids.

Epigenomic profiling links IGF2 overexpression to anthracycline resistance in colorectal cancer organoids.

Journal: JCI insight

Published: July 20, 2026

Epigenomic profiling links IGF2 oveexpression to anthracycline resistance in colorectal cancer organoids.

Epigenomic profiling links IGF2 oveexpression to anthracycline resistance in colorectal cancer organoids.

Journal: JCI insight

Published: July 20, 2026

Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

Journal: JCO precision oncology

Published: July 10, 2026

Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

Journal: JCO precision oncology

Published: July 10, 2026

Phase 2 Study of Futibatinib in Combination with Pembrolizumab in Patients with FGF19 expressing Advanced Hepatocellular Carcinoma.

Phase 2 Study of Futibatinib in Combination with Pembrolizumab in Patients with FGF19 expressing Advanced Hepatocellular Carcinoma.

Journal: The oncologist

Published: June 11, 2026

Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories.

Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories.

Journal: ArXiv

Published: June 05, 2026

Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection.

Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 29, 2025

Spatial Conformation of Pancreatic Cancer Is Associated with Disease Recurrence after Curative-Intent Total Neoadjuvant Therapy.

Spatial Conformation of Pancreatic Cancer Is Associated with Disease Recurrence after Curative-Intent Total Neoadjuvant Therapy.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53.

KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53.

Journal: The Journal of biological chemistry

Published: November 04, 2025

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.

Journal: Nature medicine

Published: October 15, 2025

Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer.

Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer.

Journal: PloS one

Published: September 27, 2025

Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.

Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.

Journal: Seminars in radiation oncology

Published: May 08, 2025

Showing 1-12 of 56

Last Updated: 09/26/2026